These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 38378361

  • 1. Inhibitory Impact Of Cinobufagin In Triple-Negative Breast Cancer Metastasis: Involvements Of Macrophage Reprogramming Through Upregulated MME and Inactivated FAK/STAT3 Signaling.
    Zhu Z, Wang H, Qian X, Xue M, Sun A, Yin Y, Tang J, Zhang J.
    Clin Breast Cancer; 2024 Jun; 24(4):e244-e257.e1. PubMed ID: 38378361
    [Abstract] [Full Text] [Related]

  • 2. Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways.
    Deng XX, Jiao YN, Hao HF, Xue D, Bai CC, Han SY.
    J Ethnopharmacol; 2021 Jun 28; 274():113978. PubMed ID: 33716082
    [Abstract] [Full Text] [Related]

  • 3. Lidocaine combined with general anesthetics impedes metastasis of breast cancer cells via inhibition of TGF-β/Smad-mediated EMT signaling by reprogramming tumor-associated macrophages.
    Seok Han B, Ko S, Seok Park M, Ji Lee Y, Eun Kim S, Lee P, Jin Cho Y, Gyeol Go H, Kwak S, Park E, Lim A, Lee S, Yoo S, Kim H, Hee Jung K, Hong SS.
    Int Immunopharmacol; 2024 Dec 05; 142(Pt B):113207. PubMed ID: 39312860
    [Abstract] [Full Text] [Related]

  • 4. Tamoxifen reverses epithelial-mesenchymal transition by demethylating miR-200c in triple-negative breast cancer cells.
    Wang Q, Cheng Y, Wang Y, Fan Y, Li C, Zhang Y, Wang Y, Dong Q, Ma Y, Teng YE, Qu X, Liu Y.
    BMC Cancer; 2017 Jul 19; 17(1):492. PubMed ID: 28724364
    [Abstract] [Full Text] [Related]

  • 5. Tumor-associated macrophages promote epithelial-mesenchymal transition and the cancer stem cell properties in triple-negative breast cancer through CCL2/AKT/β-catenin signaling.
    Chen X, Yang M, Yin J, Li P, Zeng S, Zheng G, He Z, Liu H, Wang Q, Zhang F, Chen D.
    Cell Commun Signal; 2022 Jun 17; 20(1):92. PubMed ID: 35715860
    [Abstract] [Full Text] [Related]

  • 6. Vitexin Inhibits TNBC Progression and Metastasis by Modulating Macrophage Polarization Through EGFR Signaling.
    Lin Y, Li L, Huang H, Wen X, Zhang Y, Zhang R, Huang W.
    J Immunother; 2024 Oct 01; 47(8):303-312. PubMed ID: 38847148
    [Abstract] [Full Text] [Related]

  • 7. Taurine Inhibits Lung Metastasis in Triple-Negative Breast Cancer by Modulating Macrophage Polarization Through PTEN-PI3K/Akt/mTOR Pathway.
    Lin Y, Huang Y, Zheng Y, Chen W, Zhang Y, Yang Y, Huang W.
    J Immunother; 2024 Oct 01; 47(9):369-377. PubMed ID: 38630910
    [Abstract] [Full Text] [Related]

  • 8. Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET) states.
    Yoshida T, Ozawa Y, Kimura T, Sato Y, Kuznetsov G, Xu S, Uesugi M, Agoulnik S, Taylor N, Funahashi Y, Matsui J.
    Br J Cancer; 2014 Mar 18; 110(6):1497-505. PubMed ID: 24569463
    [Abstract] [Full Text] [Related]

  • 9. The Antimicrobial Peptide Merecidin Inhibit the Metastasis of Triple-Negative Breast Cancer by Obstructing EMT via miR-30d-5p/Vimentin.
    Ma F, Song J, He M, Wang X.
    Technol Cancer Res Treat; 2024 Mar 18; 23():15330338241281310. PubMed ID: 39267432
    [Abstract] [Full Text] [Related]

  • 10. FAK activation is required for IGF1R-mediated regulation of EMT, migration, and invasion in mesenchymal triple negative breast cancer cells.
    Taliaferro-Smith L, Oberlick E, Liu T, McGlothen T, Alcaide T, Tobin R, Donnelly S, Commander R, Kline E, Nagaraju GP, Havel L, Marcus A, Nahta R, O'Regan R.
    Oncotarget; 2015 Mar 10; 6(7):4757-72. PubMed ID: 25749031
    [Abstract] [Full Text] [Related]

  • 11. Luteolin suppresses the metastasis of triple-negative breast cancer by reversing epithelial-to-mesenchymal transition via downregulation of β-catenin expression.
    Lin D, Kuang G, Wan J, Zhang X, Li H, Gong X, Li H.
    Oncol Rep; 2017 Feb 10; 37(2):895-902. PubMed ID: 27959422
    [Abstract] [Full Text] [Related]

  • 12. Discovery of a natural small-molecule compound that suppresses tumor EMT, stemness and metastasis by inhibiting TGFβ/BMP signaling in triple-negative breast cancer.
    Di L, Liu LJ, Yan YM, Fu R, Li Y, Xu Y, Cheng YX, Wu ZQ.
    J Exp Clin Cancer Res; 2019 Mar 21; 38(1):134. PubMed ID: 30898152
    [Abstract] [Full Text] [Related]

  • 13. Emodin reduces Breast Cancer Lung Metastasis by suppressing Macrophage-induced Breast Cancer Cell Epithelial-mesenchymal transition and Cancer Stem Cell formation.
    Liu Q, Hodge J, Wang J, Wang Y, Wang L, Singh U, Li Y, Yao Y, Wang D, Ai W, Nagarkatti P, Chen H, Xu P, Murphy EA, Fan D.
    Theranostics; 2020 Mar 21; 10(18):8365-8381. PubMed ID: 32724475
    [Abstract] [Full Text] [Related]

  • 14. MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer.
    Weng YS, Tseng HY, Chen YA, Shen PC, Al Haq AT, Chen LM, Tung YC, Hsu HL.
    Mol Cancer; 2019 Mar 18; 18(1):42. PubMed ID: 30885232
    [Abstract] [Full Text] [Related]

  • 15. Ononin inhibits triple-negative breast cancer lung metastasis by targeting the EGFR-mediated PI3K/Akt/mTOR pathway.
    Ganesan K, Xu C, Wu J, Du B, Liu Q, Sui Y, Song C, Zhang J, Tang H, Chen J.
    Sci China Life Sci; 2024 Sep 18; 67(9):1849-1866. PubMed ID: 38900236
    [Abstract] [Full Text] [Related]

  • 16. Cinobufagin inhibits M2‑like tumor‑associated macrophage polarization to attenuate the invasion and migration of lung cancer cells.
    Sun Y, Lian Y, Mei X, Xia J, Feng L, Gao J, Xu H, Zhang X, Yang H, Hao X, Feng Y.
    Int J Oncol; 2024 Nov 18; 65(5):. PubMed ID: 39301639
    [Abstract] [Full Text] [Related]

  • 17. 13-Methyl-palmatrubine shows an anti-tumor role in non-small cell lung cancer via shifting M2 to M1 polarization of tumor macrophages.
    Wu Z, Zhou J, Chen F, Yu J, Li H, Li Q, Li W.
    Int Immunopharmacol; 2022 Mar 18; 104():108468. PubMed ID: 35066343
    [Abstract] [Full Text] [Related]

  • 18. Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cells.
    Rigiracciolo DC, Santolla MF, Lappano R, Vivacqua A, Cirillo F, Galli GR, Talia M, Muglia L, Pellegrino M, Nohata N, Di Martino MT, Maggiolini M.
    J Exp Clin Cancer Res; 2019 Feb 06; 38(1):58. PubMed ID: 30728047
    [Abstract] [Full Text] [Related]

  • 19. Tumor-associated macrophages of the M1/M2 phenotype are involved in the regulation of malignant biological behavior of breast cancer cells through the EMT pathway.
    Chen Z, Wu J, Wang L, Zhao H, He J.
    Med Oncol; 2022 May 16; 39(5):83. PubMed ID: 35570226
    [Abstract] [Full Text] [Related]

  • 20. PDSS1-Mediated Activation of CAMK2A-STAT3 Signaling Promotes Metastasis in Triple-Negative Breast Cancer.
    Yu TJ, Liu YY, Li XG, Lian B, Lu XX, Jin X, Shao ZM, Hu X, Di GH, Jiang YZ.
    Cancer Res; 2021 Nov 01; 81(21):5491-5505. PubMed ID: 34408002
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.